{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:42:13Z","timestamp":1792784533555,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"29-30","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["R01AI072060"],"award-info":[{"award-number":["R01AI072060"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.vaccine.2011.04.057","type":"journal-article","created":{"date-parts":[[2011,5,8]],"date-time":"2011-05-08T09:30:47Z","timestamp":1304847047000},"page":"4853-4861","source":"Crossref","is-referenced-by-count":36,"title":["Immune responses to an attenuated West Nile virus NS4B-P38G mutant strain"],"prefix":"10.1016","volume":"29","author":[{"given":"Thomas","family":"Welte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guorui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason A.","family":"Wicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa C.","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Rachamallu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5448","key":"10.1016\/j.vaccine.2011.04.057_bib0005","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1126\/science.286.5448.2331","article-title":"Isolation of West Nile virus from mosquitoes, crows, and a Cooper's hawk in Connecticut","volume":"286","author":"Anderson","year":"1999","journal-title":"Science"},{"issue":"5448","key":"10.1016\/j.vaccine.2011.04.057_bib0010","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1126\/science.286.5448.2333","article-title":"Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States","volume":"286","author":"Lanciotti","year":"1999","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.vaccine.2011.04.057_bib0015","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(02)00368-7","article-title":"West Nile virus","volume":"2","author":"Campbell","year":"2002","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2011.04.057_bib0020","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays","volume":"75","author":"Davis","year":"2001","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.04.057_bib0025","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.4049\/jimmunol.167.9.5273","article-title":"Immunization of mice against West Nile virus with recombinant envelope protein","volume":"167","author":"Wang","year":"2001","journal-title":"J Immunol"},{"issue":"17","key":"10.1016\/j.vaccine.2011.04.057_bib0030","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant West Nile virus vaccine","volume":"103","author":"Monath","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"May (Pt 5)","key":"10.1016\/j.vaccine.2011.04.057_bib0035","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1099\/0022-1317-73-5-1115","article-title":"Broad cross-reactivity with marked fine specificity in the cytotoxic T cell response to flaviviruses","volume":"73","author":"Hill","year":"1992","journal-title":"J Gen Virol"},{"issue":"February (8)","key":"10.1016\/j.vaccine.2011.04.057_bib0040","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1073\/pnas.0711874105","article-title":"Epitope discovery in West Nile virus infection: identification and immune recognition of viral epitopes","volume":"105","author":"McMurtrey","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2011.04.057_bib0045","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.virol.2006.11.012","article-title":"A mouse cell-adapted NS4B mutation attenuates West Nile virus RNA synthesis","volume":"361","author":"Puig-Basagoiti","year":"2007","journal-title":"Virology"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.04.057_bib0050","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.virol.2007.02.009","article-title":"Mutations in West Nile virus nonstructural proteins that facilitate replicon persistence in vitro attenuate virus replication in vitro and in vivo","volume":"364","author":"Rossi","year":"2007","journal-title":"Virology"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2011.04.057_bib0055","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1128\/JVI.01161-09","article-title":"The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling","volume":"84","author":"Laurent-Rolle","year":"2010","journal-title":"J Virol"},{"issue":"February (3)","key":"10.1016\/j.vaccine.2011.04.057_bib0060","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1128\/JVI.79.3.1934-1942.2005","article-title":"Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins","volume":"79","author":"Liu","year":"2005","journal-title":"J Virol"},{"issue":"July (13)","key":"10.1016\/j.vaccine.2011.04.057_bib0065","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1128\/JVI.79.13.8004-8013.2005","article-title":"Inhibition of alpha\/beta interferon signaling by the NS4B protein of flaviviruses","volume":"79","author":"Munoz-Jordan","year":"2005","journal-title":"J Virol"},{"issue":"November (21)","key":"10.1016\/j.vaccine.2011.04.057_bib0070","doi-asserted-by":"crossref","first-page":"11809","DOI":"10.1128\/JVI.00791-07","article-title":"Differential effects of mutations in NS4B on West Nile virus replication and inhibition of interferon signaling","volume":"81","author":"Evans","year":"2007","journal-title":"J Virol"},{"issue":"June (2)","key":"10.1016\/j.vaccine.2011.04.057_bib0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.virol.2006.03.007","article-title":"A single amino acid substitution in the central portion of the West Nile virus NS4B protein confers a highly attenuated phenotype in mice","volume":"349","author":"Wicker","year":"2006","journal-title":"Virology"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2011.04.057_bib0080","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1074-7613(00)80596-8","article-title":"Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function","volume":"9","author":"Adachi","year":"1998","journal-title":"Immunity"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.04.057_bib0085","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.immuni.2008.11.012","article-title":"Toll-like receptor 7 mitigates lethal West Nile encephalitis via interleukin 23-dependent immune cell infiltration and homing","volume":"30","author":"Town","year":"2009","journal-title":"Immunity"},{"issue":"September (17)","key":"10.1016\/j.vaccine.2011.04.057_bib0090","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1128\/JVI.00918-08","article-title":"Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection","volume":"82","author":"Daffis","year":"2008","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2011.04.057_bib0095","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1128\/JCM.38.11.4066-4071.2000","article-title":"Rapid detection of West Nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay","volume":"38","author":"Lanciotti","year":"2000","journal-title":"J Clin Microbiol"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.04.057_bib0100","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/nm1140","article-title":"Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis","volume":"10","author":"Wang","year":"2004","journal-title":"Nat Med"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.04.057_bib0105","doi-asserted-by":"crossref","first-page":"8568","DOI":"10.4049\/jimmunol.181.12.8568","article-title":"West Nile virus-specific CD4T cells exhibit direct antiviral cytokine secretion and cytotoxicity and are sufficient for antiviral protection","volume":"181","author":"Brien","year":"2008","journal-title":"J Immunol"},{"issue":"July 7","key":"10.1016\/j.vaccine.2011.04.057_bib0110","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/eji.200737196","article-title":"Protective capacity and epitope specificity of CD8(+) T cells responding to lethal West Nile virus infection","volume":"37","author":"Brien","year":"2007","journal-title":"Eur J Immunol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2011.04.057_bib0115","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/eji.200737192","article-title":"Antigen-specific cytotoxic T lymphocytes protect against lethal West Nile virus encephalitis","volume":"37","author":"Purtha","year":"2007","journal-title":"Eur J Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.04.057_bib0120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/JCM.42.1.65-72.2004","article-title":"Detection of human anti-flavivirus antibodies with a West Nile virus recombinant antigen microsphere immunoassay","volume":"42","author":"Wong","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.04.057_bib0125","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/viro.2002.1372","article-title":"Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype","volume":"296","author":"Beasley","year":"2002","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2011.04.057_bib0130","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/088282403322396082","article-title":"Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus","volume":"16","author":"Diamond","year":"2003","journal-title":"Viral Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.04.057_bib0135","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/JVI.80.1.119-129.2006","article-title":"CD8+ T cells require perforin to clear West Nile virus from infected neurons","volume":"80","author":"Shrestha","year":"2006","journal-title":"J Virol"},{"issue":"December (24)","key":"10.1016\/j.vaccine.2011.04.057_bib0140","doi-asserted-by":"crossref","first-page":"13323","DOI":"10.1128\/JVI.77.24.13323-13334.2003","article-title":"CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis","volume":"77","author":"Wang","year":"2003","journal-title":"J Virol"},{"issue":"December","key":"10.1016\/j.vaccine.2011.04.057_bib0145","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1749-6632.2001.tb02704.x","article-title":"Antibody prophylaxis and therapy for flavivirus encephalitis infections","volume":"951","author":"Roehrig","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2011.04.057_bib0150","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1017\/S0022172400022476","article-title":"The mechanism of cross-protection afforded by dengue virus against West Nile virus in hamsters","volume":"70","author":"Price","year":"1972","journal-title":"J Hyg (Lond)"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2011.04.057_bib0155","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/JVI.77.4.2578-2586.2003","article-title":"B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus","volume":"77","author":"Diamond","year":"2003","journal-title":"J Virol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.04.057_bib0160","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptive immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat Immunol"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2011.04.057_bib0165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-2478(02)00228-6","article-title":"Recognition of pathogen-associated molecular patterns by TLR family","volume":"85","author":"Akira","year":"2003","journal-title":"Immunol Lett"},{"issue":"September","key":"10.1016\/j.vaccine.2011.04.057_bib0170","article-title":"The innate immune adaptor molecule MyD88 restricts West Nile replication and spread in neurons of the central nervous system","author":"Szretter","year":"2010","journal-title":"J Virol"},{"issue":"August (36)","key":"10.1016\/j.vaccine.2011.04.057_bib0175","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1016\/j.vaccine.2010.06.045","article-title":"Characterization of West Nile virus live vaccine candidates attenuated by capsid deletion mutations","volume":"28","author":"Schlick","year":"2010","journal-title":"Vaccine"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2011.04.057_bib0180","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses","volume":"28","author":"Guy","year":"2010","journal-title":"Vaccine"},{"issue":"March 6","key":"10.1016\/j.vaccine.2011.04.057_bib0185","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.4049\/jimmunol.162.6.3256","article-title":"Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells","volume":"162","author":"Curtsinger","year":"1999","journal-title":"J Immunol"},{"issue":"November (3)","key":"10.1016\/j.vaccine.2011.04.057_bib0190","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1365-2567.2009.03128.x","article-title":"MyD88 and interferon-alpha\/beta are differentially required for dendritic cell maturation but dispensable for development of protective memory against Listeria","volume":"128","author":"Tam","year":"2009","journal-title":"Immunology"},{"issue":"February 3","key":"10.1016\/j.vaccine.2011.04.057_bib0195","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.189.3.521","article-title":"Type I interferons keep activated T cells alive","volume":"189","author":"Marrack","year":"1999","journal-title":"J Exp Med"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2011.04.057_bib0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nri2251","article-title":"Shaping and reshaping CD8+ T-cell memory","volume":"8","author":"Harty","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"June","key":"10.1016\/j.vaccine.2011.04.057_bib0205","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.0105-2896.2006.00382.x","article-title":"Signals required for programming effector and memory development by CD8+ T cells","volume":"211","author":"Mescher","year":"2006","journal-title":"Immunol Rev"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.04.057_bib0210","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/87720","article-title":"Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells","volume":"2","author":"Kaech","year":"2001","journal-title":"Nat Immunol"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.04.057_bib0215","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1007\/s10620-006-9693-0","article-title":"Factors influencing treatment efficacy of 24-week combination therapy with interferon alpha-2b plus ribavirin for chronic hepatitis C","volume":"52","author":"Moriyama","year":"2007","journal-title":"Dig Dis Sci"},{"issue":"September (17)","key":"10.1016\/j.vaccine.2011.04.057_bib0220","doi-asserted-by":"crossref","first-page":"8262","DOI":"10.1128\/JVI.00226-08","article-title":"West Nile virus nonstructural protein 1 inhibits TLR3 signal transduction","volume":"82","author":"Wilson","year":"2008","journal-title":"J Virol"},{"issue":"July (14)","key":"10.1016\/j.vaccine.2011.04.057_bib0225","doi-asserted-by":"crossref","first-page":"7737","DOI":"10.1128\/JVI.78.14.7737-7747.2004","article-title":"The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway","volume":"78","author":"Fredericksen","year":"2004","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11006025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11006025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T11:56:37Z","timestamp":1712404597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11006025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":45,"journal-issue":{"issue":"29-30","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0264410X11006025"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.04.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}